Walter Mier - Concepedia

Author

Walter Mier

Heidelberg University ORCID

Also Known As

Mier, W., U Haberkorn, W Mier, W. Mier, Walter Mier

315

Publications

19.5K

Citations

H-Index

195

Concepts

All Affiliations

Heidelberg University University Hospital Heidelberg German Cancer Research Center National Center for Tumor Diseases German Center for Lung Research

About

Walter Mier is an author at Heidelberg University specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	57	6K
2	Engineering	20	26	3.3K
3	Health Sciences	15	15	1.1K
4	Natural Sciences	14	18	1.7K
5	Social Sciences	1	1	695

Walter Mier

162

Publications

17.7K

Citations

H-Index

Page 1

	Year	Citations
<sup>68</sup>Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer Clemens Kratochwil, Paul Flechsig, Thomas Lindner, Journal of Nuclear Medicine	2019	1.4K
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein Thomas Lindner, Anastasia Loktev, Annette Altmann, Journal of Nuclear Medicine EngineeringTumor BiologyTheranosticsFibroblast Growth FactorAnti-cancer Agent	2018	874
<sup>68</sup>Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging Matthias Eder, Martin Schäfer, Ulrike Bauder‐Wüst, Bioconjugate Chemistry EngineeringImaging AgentUrea-based InhibitorsChemical BiologyUrea-based Psma Inhibitor	2012	824
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts Anastasia Loktev, Thomas Lindner, Walter Mier, Journal of Nuclear Medicine EngineeringOncologic ImagingPathologyCancer-associated FibroblastsTumor Biology	2018	729
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis Armin Schneider, Carola Krüger, Tobias Steigleder, Journal of Clinical Investigation Propose G-csfCell DeathSocial SciencesCerebral Vascular RegulationNeuroinflammation	2005	695
<sup>68</sup>Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers Frederik L. Giesel, Clemens Kratochwil, Thomas Lindner, Journal of Nuclear Medicine	2018	674
PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with <sup>177</sup>Lu-Labeled PSMA-617 Clemens Kratochwil, Frederik L. Giesel, M. Stefanova, Journal of Nuclear Medicine	2016	598
Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer Martina Benešová, Martin Schäfer, Ulrike Bauder‐Wüst, Journal of Nuclear Medicine	2015	576
F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients Frederik L. Giesel, Boris Hadaschik, Jens Cardinale, European Journal of Nuclear Medicine and Molecular Imaging	2016	573
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients Ali Afshar‐Oromieh, Tim Holland‐Letz, Frederik L. Giesel, European Journal of Nuclear Medicine and Molecular Imaging	2017	509

Page 1